Choose 1 option.

The correct answer is C because sample visibility during visits depends on the product being configured as a Life Sciences Marketable Product with an appropriate distribution method. Salesforce Help for setting up Sample Inventory Management data states that, to designate a product as a sample product, administrators create a corresponding Life Science Marketable Product record. Salesforce’s Life Sciences Cloud Developer Guide for LifeSciMarketableProduct identifies distribution methods such as Drop , DropAndShip , and Ship , which define how a product is distributed to a provider.

In a provider visit, a product must be configured as marketable and available for the relevant distribution method before reps can select it for sample drop-off. If the product is meant to be handed directly to the HCP during the visit, the distribution method must include Drop . If it can be either handed off during the visit or shipped, Drop and Ship is appropriate. This setup makes the product eligible for visit-based sampling workflows.

Option A is incorrect because permissions alone do not make a specific sample product visible. Reps may have access to sampling functionality, but the product still must be configured correctly. Option B is also incorrect because profile configuration in Visit Administration is not the key product-availability control. The essential configuration is the Life Sciences Marketable Product record with the correct distribution method. Therefore, the consultant should set the distribution method to Drop or Drop and Ship .